Tumor markers in peripheral blood of patients with malignant melanoma: Multimarker RT-PCR versus a luminoimmunometric assay for S-100

Archives of Dermatological Research

Volumn 291, Issue 9, 1999, Pages 479-484

  Berking, Carola ^a   Schlüpen, Eva Maria ^a   Schrader, Andres ^b,c   Atzpodien, Jens ^b,c   Volkenandt, Matthias ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Robert Janker Klinik   (Germany)

Author keywords

Hematogenous spread; Malignant melanoma; Polymerase chain reaction; S 100 protein; Tyrosinase

Indexed keywords

MONOPHENOL MONOOXYGENASE; PROTEIN S 100; TUMOR MARKER;

ARTICLE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

HUMANS; IMMUNOLOGIC TECHNIQUES; MELANOMA; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032824803     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050441     Document Type: Article

References (31)

1. Abraha HD, Fuller LC, Do Vivier AW, Higgins EM, Sherwood RA (1991) Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. Br J Dermatol 137: 381-385
2. Adema GJ, de BA, Vogel AM, Loenen WA, Figdor CG (1994) Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 269: 20126-20133
3. Battayani Z, Grob JJ, Xerri L, Noe C, Zarour K Houvaeneghel G, Delpero JR, Birnbaum D, Hassoun J, Bonerandi JJ (1995) Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131: 443-447
4. Brossart P, Keilholz U, Scheibenbogen C, Mohler T, Willhauck M, Hunstein W (1994) Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J Immunother 15: 38-41
5. Brossart P, Schmier JW, Kruger S, Willhauck M, Scheibenbogen C, Mohler T, Keilholz U (1995) A polymerase chain reaction-based semiquantitive assessment of malignant melanoma cells in peripheral blood. Cancer Res 55: 4065-4068
6. Brouwenstijn N, Stager EK Bakker AB, Schreurs MW, Van der Spek Cw, Adema, GJ, Schrier PI, Figdor CG (1997) Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage. Br J Cancer 76: 1562-1566
7. Buer J, Probst M, Franzke A, Duensing S, Haindl J, Volkenandt K Wittke F, Hoffmann R, Ganser A, Atzpodien J (1997) Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer 75: 1373-1376
8. Coulie PG, Brichard V, Van PA, Wolfel T, Schneider J, Traversari C, Mattei S, De PE, Lurquin C, Szikora JP, et al (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180: 35-42
9. Curry BJ, Smith MJ, Hersey P (1996) Detection and quantitation of melanoma cells in the circulation of patients. Melanoma Res 6: 45-54
10. Fassbender K, Schmidt R, Schreiner A, Fatar K Muhlhauser F, Daffertshofer K, Hennerici M (1997) Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 148: 101-105
11. Foss AJ, Guille MJ, Occleston NT, Hykin PG, Flungedord JL, Lightman S (1995) The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72: 155-159
12. Gaugler B, Van dEB, Van dBP, Romero P, Gaforio JJ, De PE, Lethe B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179: 921-930
13. Gläser R, Rass K, Seiter S, Hauschild A, Christophers E, Tilgen W (1997) Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 15: 2818-2825
14. Guo HB, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmüller D (1995) Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 31(6): 924-928
15. Henze G, Dummer F, Joller-Jemelka HI, Böni R, Burg G (1997) Serum S100 - a marker for disease monitoring in metastatic melanoma. Dermatology 194: 208-212
16. Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze Al, Morton DL (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13: 2109-2116
17. Jung FA, Buzaid AC, Ross MI, Woods KV, Lee JJ, Albitar K, Grimm EA (1997) Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J Clin Oncol 15: 2826-2831
18. Jung FA, Buzaid AC, Woods KV, Ross K, Grimm EA (1996) Detection of melanoma cells in peripheral blood using reverse transcription polymerase chain reaction assay for tyrosinase mRNA. Cancer Surv 26: 251-265
19. Kunter U, Buer I, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EM, Volkenandt M, Ganser A, Atzpodien J (1996) Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88: 590-594
20. Mellado B, Colomer D, Castel T, Munoz M, Carballo E, Galan M, Mascaro JM, Vives CJ, Grau JJ, Estape J (1996) Detection of circulating neoplastic cells by reverse-transcriptase, polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 14: 2091-2097
21. Pittman K, Burchill S, Smith B, Southgate J, Joffe J, Gore M, Selby P (1996) Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 7: 297-301
22. Probst KM, Schrader A, Buer J, Grosse J, Volkenandt M, Illiger HJ, Metzner B, Kadar J, Duensing S, Hertenstein B, Ganser A, Atzpodien J (1997) Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma. Br J Haematol 98: 488-490
23. Proebstle TM, Huber R, Sterry W (1996) Detection of early micrometastases in subcutaneous fat of primary malignant melanoma patients by identification of tyrosinase-mRNA. Eur J Cancer 32A(10): 1664-1667
24. Reinhold U, Ludtke HH, Schnautz S, Kreysel HW, Abken H (1997) The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 108: 166-169
25. Sarantou T, Chi DD, Garrison DA, Conrad AJ, Schmid P, Morton DL, Hoon DS (1997) Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 57: 1371-1376
26. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1229
27. Stevens GL, Scheer ArD, Levine EA (1996) Detection of tyrosinase mRNA from the blood of melanoma patients. Cancer Epidemiol Biomarkers Prev 5: 293-296
28. Taggart DP, Bhattacharya K, Meston N, Standing SJ, Kay JD, Pillai I, Johnsson P, Westaby S (1997) Serum S-protein concentration after cardiac surgery: a randomized trial of arterial line filtration. Eur J Cardiothorac Surg 11: 645-649
29. Tobal K, Sherman LS, Foss AJ, Lightman SL (1993) Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sci 34: 2622-2625
30. Van der Velde Zimmermann D, Roijers JF, Bouwens RA, De WR, De GP, Tilanus MG, Van dTJ (1996) Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 149: 759-764
31. von Schoultz E, Hansson LO, Djureen E, Hansson J, Karnell R, Nilsson B, Stigbrand T, Ringborg U (1996) Prognostic value of serum analyses of S-100 beta protein in malignant melanoma. Melanoma Res 6: 133-137